Advertisement

Topics

Heat Biologics, Inc.: Heat Biologics Reports Third Quarter 2018 Results and Provides Corporate Update

08:08 EST 15 Nov 2018 | FinanzNachrichten

On track to report key clinical milestones beginning in Q4 2018 DURHAM, NC / ACCESSWIRE / November 15, 2018 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing therapies d...

Original Article: Heat Biologics, Inc.: Heat Biologics Reports Third Quarter 2018 Results and Provides Corporate Update

NEXT ARTICLE

More From BioPortfolio on "Heat Biologics, Inc.: Heat Biologics Reports Third Quarter 2018 Results and Provides Corporate Update"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...